US3592191A - Recovery of anesthetic agents - Google Patents

Recovery of anesthetic agents Download PDF

Info

Publication number
US3592191A
US3592191A US791910*A US3592191DA US3592191A US 3592191 A US3592191 A US 3592191A US 3592191D A US3592191D A US 3592191DA US 3592191 A US3592191 A US 3592191A
Authority
US
United States
Prior art keywords
anesthetic agent
gaseous mixture
anesthetic
gas
extracting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US791910*A
Inventor
Richard R Jackson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of US3592191A publication Critical patent/US3592191A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0087Environmental safety or protection means, e.g. preventing explosion
    • A61M16/009Removing used or expired gases or anaesthetic vapours
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0087Environmental safety or protection means, e.g. preventing explosion
    • A61M16/009Removing used or expired gases or anaesthetic vapours
    • A61M16/0093Removing used or expired gases or anaesthetic vapours by adsorption, absorption or filtration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/22Carbon dioxide-absorbing devices ; Other means for removing carbon dioxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/08Bellows; Connecting tubes ; Water traps; Patient circuits
    • A61M16/0808Condensation traps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0208Oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/03Gases in liquid phase, e.g. cryogenic liquids

Definitions

  • the anesthetic agent is then extracted l28/l 88, WI, 186, -1423, I85, I89. I from the dried gas by a cryogenic process in which the vapors I466, 19].! 202, 142, I425, 145.8. I96 in the anesthetic agent are condensed to a liquid phase or by an absorbent material which is processed later to remove the [56] References cued agent.
  • the UNITED STATES PATENTS anesthetic condensate is collected and may be readmitted 3,128,764 4/l964 Koehn l28/l88 directly into the anesthetic system.
  • My invention is directed to a method and apparatus for increasing the efl'tciency of existing systems for administering an inhalation anesthetic agent to a patient. More particularly, it relates to those anesthetic delivery systems in which a portion of the anesthetic agent which is delivered to but not taken up by the patient normally is exhausted to the atmosphere. It is among the primary objects of my invention to provide a method and apparatus for recovering that portion of the anesthetic agent which normally is exhausted from such a system. My invention is particularly useful when the employed anesthetic agent is relatively expensive, such as halothane which is a commonly used name for Lbromo-Z-chloro-l, I, l-trifluoroethane.
  • a number of systems have been employed in the prior art to deliver a gaseous mixture bearing an inhalation anesthetic to a patient.
  • these systems are the open system" in which that portion of the delivered gaseous mixture which is not taken up by the patient is exhausted completely to the atmosphere and there is no recirculation of any portion of the gaseous mixture to the patient.
  • the closed system the anesthetic gases are delivered to the patient and the gases not taken up by the patient then are returned to the circuit so that there is a negligible loss of gas to the atmosphere.
  • the rate with which the patients tissues take up the anesthetic agent is dependent on the amount of agent added to the circuit.
  • the amount of agent added to the circuit must be carefully controlled so that as the patients rate of uptake decreases the amount of agent added as the circuit is reduced. Failure to reduce accurately the quantity of agent added to the system, as the depth of anesthesia increases, may tend to cause the patient to become saturated with anesthetic to a degree in excess of that which is necessary for maintenance of anesthesia. If the rate of introduction of anesthetic into the closed circuit is not controlled properly the patient may become saturated dangerously to the degree where cardiac arrest or dangerously low blood pressure may occur.
  • Another system is the "semiclosed system," in which a portion of the gases flowing through the circuit is exhausted from the circuit.
  • This arrangement permits fresh gases to be introduced into the circuit at a relatively high flow rate. It has been found that when the fresh gas is introduced into the circuit at a flow rate that is considerably greater than the respiratory rate or minute volume of the patient, the tendency for the patient to become saturated excessively with the agent is reduced materially. This eliminates the need to monitor and adjust continually the amount of anesthetic agent introduced into the system as the patients depth of anesthesia increases.
  • One of the disadvantages of employing the semiclosed technique is that a considerable portion of the anesthetic agent, which is not taken up by the patient is exhausted to the atmosphere.
  • the exhausted gas is collected and then is processed, externally of the anesthesia circle, to remove the particular anesthetic component.
  • the anesthetic then may be readmitted to the circle for immediate reuse or may be stored for use at a later time.
  • a number of methods may be employed for extracting the anesthetic component from the exhausted gas, the illustrative embodiments of my invention employing either a cryogenic or absorption technique.
  • the gases are exhausted from the circle at a location that is downstream from the patient uptake station or inhalation mask so that the exhausted gas may be saturated with water vapor exhaled by the patient.
  • the remaining gas, which includes the anesthetic agent is then extracted by further cooling to a yet lower temperature at which the anesthetic agent will condense to its liquid phase.
  • the liquid anesthetic agent then may be readmitted directly into the vaporizer of the anesthesia circle and thus be reused immediately.
  • the exhausted gas will contain additional contaminants exhaled by the patient, such as carbon dioxide and, possibly, hydrocarbon gases.
  • the patient may have been anesthetized earlier with another anesthetic agent and the exhaled gases may include this as well.
  • Another aspect of my invention is directed to a technique and an arrangement for readmitting the anesthetic to a secondary vaporizer, located externally of the anesthesia circle, to isolate the contaminants so that they may be in communication only with the patient from which they originated as well as to preclude contamination of the main source of anesthetic agent.
  • My technique may be employed to extract the anesthetic agent by a condensation process which enables immediate reuse of the condensate or, alternatively, to the anesthetic agent from the exhausted gas by passing the gas through a material which is capable of absorbing the particular anesthetic agent.
  • a material which is capable of absorbing the particular anesthetic agent For example, when halothane is employed as the anesthetic agent, activated charcoal may be used as the absorbent material. The absorbent material bearing the agent then may be retained for processing at a later time to extract and purify the agent.
  • FIG. I is an illustration of a conventional semiclosed system for administering an inhalation anesthetic
  • FIG. 2 is an illustration of an embodiment of my invention by which the inhalation anesthetic is recovered by a cryogenic process
  • FIG. 3 is an illustration of a conventional semiclosed system, modified in accordance with my invention to recover the anesthetic agent which normally would be exhausted to the atmosphere;
  • FIG. 4 is an illustration of a closed system employing my technique of recovering the anesthetic agent
  • FIG. 5 shows an anesthetic delivery system including means for recovering the uninspired anesthetic agent and means for isolating the recovered agent to preclude contamination of the primary source of anesthetic;
  • FIG. 6 shows an alternative arrangement for extracting cryogenically the anesthetic agent from the uninspired gas
  • FIG. 7 is an illustration of another technique for extracting the anesthetic agent.
  • the conventional semiclosed system for delivering an inhalation anesthetic agent to a patient includes a breathing mask 10 which is positioned over the patients mouth and into which the patient breathes.
  • An inlet hose l2 and an outlet hose 14 are connected to the mask I0 respectively, to deliver a flow of fresh gas to the mask 10 and to conduct the mixed exhaled gas and uninspired gases away from the mask 10.
  • the hoses 12, I4 are provided with one-way valves I6, l8 which insure unidirectional flow through the mask 10.
  • the gaseous mixture flowing through the outlet hose 14 includes a component of exhaled gases, such as carbon dioxide
  • a canister is connected to the downstream end of the outlet hose [4.
  • the canister 20 is filled with a material which absorbs readily carbon dioxide, such as sodalime.
  • the inlet hose [2 is connected to the other end of the canister 20 to receive and conduct the processed gas, which includes a previously uninspired portion of inhalation anesthetic, to the mask 10.
  • a conventional reservoir bag 22 may be connected to the outlet hose l4 downstream of the one-way valve 18.
  • the circuitous path defined by the inlet hose l2, mask [0, outlet house 14 and canister 20 is referred to commonly as the anesthetic circle.”
  • a fresh mixture of gases including the anesthetic agent
  • the anesthetic agent is introduced continually to the anesthetic circle through the hose 24 which leads into the outlet end of the canister 20 so that the gases flowing through the hose 24 may mix with the processed gas that has passed through the soda-lime in the canister 20.
  • This mixturc is then delivered through the oneway valve 16 and inlet hose 1] to the breathing mask It).
  • the fresh, gaseous mixture passing through the hose 24 may include a mixture of oxygen and nitrous oxide which may be supplied in the desired proportions from a source 26.
  • the anesthetic agent is combined with the nitrous oxide-oxygen mixture by means of a vaporizer 28 which is interposed along the hose 24.
  • the vaporizer 28 contains a supply of liquid anesthetic agent, and is effective to vaporize the anesthetic agent so that it will mix, in predetermined and controllable ratios, with the oxygen-nitrous oxide mixture flowing into the vaporizer 28.
  • the flow rates em ployed and the proportions in which the various gases are mixed depends on the type of delivery system employed, the type of anesthetic agent utilized as well as the needs of the par-- ticular patient to be anesthetized.
  • the flow rate may be between 2-7 liters per minute of nitrous oxide-oxygen mixture of which approxi mately 0.5-2.5 percent of which is vaporized halothane.
  • a number of such vaporizers are available commercially, and, although they operate under somewhat different principles, they all are effective to produce the same results of vaporizing and mixing the anesthetic agent with the fresh flow of gas introduced to the anesthetic circle.
  • the gaseous mixture flows through the anesthetic circle at a flow rate that is greater than the uptake rate of the patient
  • a pressure responsive pop-off valve 30 formed integrally with canister 20 and which is effective to enable the excess gas in the circle to be exhausted to the atmosphere.
  • the pop-off valve 30 is located in the anesthetic circle so that the gas which escapes through the valve 30 comes from the outlet hose 14.
  • the gas flowing from the mask 10 to the hose 14 will include a number of gaseous constituents generated and exhaled by the patient in addition to the uninspired anesthetic and car bon dioxide.
  • the exhaled constituents which is present in a significant concentration is water vapor, and, in the preferred embodiment of my IIWCH tion, a considerable portion of the water vapor is removed initially from the gas.
  • the exhausted gas is collected in a bleed hose 32 which conducts the gas to a first condenser 34.
  • the condenser 34 includes a condenser coil 36 which is in communication with the bleed hose 32, the coil 36 being immersed in a ice-water bath 38. By reducing the temperature of the gas to this level, most of the water vapor present in the gas will condense on the inner walls of the coil 36
  • the coil 36 terminates in an outlet to 40 which is connected to a water trap 42.
  • the water trap is effective to permit the remaining gases to pass thercthrough into the tube 44, but to preclude the condensed water vapor from passing therethrough.
  • Reduction of the temperature to this level is effective to reduce the vapor pres sure of the anesthetic agent to a level wherein it will condense to the liquid phase on the inner surface of the coil 48.
  • the partial pressure of the halothane is reduced to less than i millimeter Hg. which is adequate to enable condensation and recovery of practically all of the halothane.
  • a drip tube 52 is connected to the outlet of the coil 48 and directs the condensed agent to a container 54 in which it may be collected.
  • Other arrangements, such as a silica-gel scrubber, may be employed, in place of the condenser arrangement for removing the water vapor from the collected gas before extraction ofthc anesthetic agent.
  • FIG. 3 The foregoing cryogenic arrangement for extracting the anesthetic agent from the gas is shown, in FIG. 3, as employed in a conventional semiclosed anesthetic delivery system. ln this arrangement the bleed hose 32 is connected directly to the pop-off valve 30 to collect and conduct the gases, which normally would be exhausted to the atmosphere, to the condensers 34 and 46.
  • the drip tube 52, leading from the second condenser 46 is connected to a liquid trap 53 which retains the condensed agent that permits the remaining, unwanted gases to be eliminated from the system.
  • the trap is connected to the vaporizer 28 to enable the recovered liquid anesthetic to be readmitted into the delivery system.
  • the foregoing arrangement may be employed in a semiclosed system in which the vaporizer 28 is located outside the anesthetic circle, as described thus far, or in an arrangement in which the vaporizer is located within the anesthetic circle.
  • Such an arrangement is shown in FIG. 4 and includes a vaporizer 54 which receives the flow from the outlet hose l4 and which is connected to the inlet of the canister 20 by the hose 56
  • the source 26 of the fresh gases is connected to the vaporizer 54 by the conduit 58.
  • the anesthetic agent which is extracted from the exhausted gas is readmitted to the anesthetic circle by the drip-tube 52 and liquid trap 53 which is connected to the vaporizer 54.
  • the patient may emit a variety of contaminant gaseous constituents from his lungs, such as volatile hydrocarbons or traces of another anesthetic agent that was previously administered to the patient, it may be desirable to isolate the ex hausted gas and the anesthetic agent extracted therefrom from the main source of agent stored in the vaporizer. This is particularly true if it is not possible practicably to eliminate these contaminants from the recovered anesthetic agent.
  • an arrangement may be employed, in accordance with my invention, to isolate the ex tracted anesthetic agent from that contained in the vaporizer. As shown in FIG.
  • this arrangement includes an anesthetic circle system in which a small, secondary vaporizer 60 is employed to collect the extracted anesthetic agent from the drip tube 52. No portion of the collected anesthetic is redirected to the main vaporizer 28 so that if any contaminants are present in the extracted anesthetic agent, they will not affect the purity of the main supply of anesthetic agent in the main vaporizer 28.
  • the recovered anesthetic is vaporized in the secondary vaporizer 60 and is combined with an oxygen-nitrous oxide mixture which flows from a source 62 through the conduit 64 into the secondary vaporizer 60.
  • a fine flow meter 66 is interposed along the conduit 64 to regulate the flow of fresh gas through the secondary vaporizer 60 so that the relatively low flow of gaseous mixture from the secondary vaporizer 60 back to the anesthetic circle along the conduit 68 will contain a large proportion of agent, for example, of the order of 30 per cent concentration.
  • This mixture introduced to the anesthetic circle through the conduit 68, is supplemented by and mixed with a flow of fresh gas from the source 26 which is regulated by the coarse flow meter 70.
  • the flow meter 70 is adjusted so that the fresh gases which are mixed with the vaporized anesthetic agent in the main vaporizer 28 will be delivered to the anesthetic circle along the conduit 14 at a flow rate and concentration which will dilute the relatively low flow and high concentration of the gas introduced along the conduit 68 to a concentration which may be safely administered to the patient. It will be appreciated that this arrangement isolates completely the extracted anesthetic agent and any contaminants contained therein from the main supply of anesthetic in the main vaporizer 28.
  • FIG. 6 includes a source 72 of liquid oxygen 74 at a temperature of approximately minus 220 C.
  • the source 72 may comprise a Dewar flask.
  • the oxygen is admitted to an insulated condenser 76 by a tube 78, the outlet of which is controlled by a thermostatic valve 80 which is adapted to regulate the flow of oxygen into the condenser 76, thereby to maintain the condenser at a temperature which is sufficient to condense substantially all of the anesthetic agent but which will not render the agent too viscous to handle.
  • the thermostatic valve 80 should control the admis sion of oxygen so that the temperature within the condenser 76 if of the order of minus 70 C.
  • a condenser coil 82 is con tained within the condenser 76 and receives the predried gas through the inlet 84 and directs the condensed anesthetic agent to the outlet 86 into a trap 88 which retains the recovered fluid anesthetic agent.
  • the trap 88 is provided with a vent 90 through which the unrecov'ered, unwanted gases may escape to the atmosphere.
  • the recovered anesthetic agent may be stored for subsequent use or may be readmitted directly into the anesthetic circle in the manners described above.
  • the condenser 76 may be provided with an outlet for the evaporated oxygen which may be redirected to the source of the fresh gas flow.
  • My invention as described thus far, relates to an arrange ment in which the water vapor is extracted from the exhausted gaseous mixture before and in separate step from the extrac' tion of the anesthetic agent, In some instances, however, it may be desirable to separate simultaneously the water vapor and anesthetic agent by employing an arrangement as shown in FIG. 7, This arrangement differs from those described previously in that the bleed hose 32 from the pop off valve 30 leads directly into the upper end ofa cryogenic condenser 94.
  • the condenser 94 includes an internal chamber 96 in which is mounted a plurality of condenser plates 98.
  • the chamber 96 is maintained at a temperature that is low enough to condense substantially all of the anesthetic agent introduced into the chamber 96 through the bleed hose 32.
  • the chamber 96 may be maintained at approximately 70 C by immersing the chamber 96 in a bath of solid carbon dioxide 50' and chamber 96.
  • Other techniques may be employed to maintain the chamber 96 at the desired temperature.
  • the temperature of the chamber 96 will cause the anesthetic agent to condense to its liquid phase on and about the condenser plates 98 from which the condensed anesthetic agent may drip downwardly toward an outlet 102 formed in the bottom of the chamber 96.
  • the ice particles will also gravitate and drift downwardly toward the outlet 102 and may form a slurry with the condensed anesthetic agent.
  • the ice particles are separated from the condensed anesthetic agent and other gases passing through the chamber 96 by means ofa suitable filter 104, such as is available commercially from the Millipore Corporation.
  • a Millipore filter effective to block the passage of particles l micron in diameter and smaller would be suitable to separate most of the frozen ice particles, yet would permit the condensed liquid anesthetic agent and other gases to pass therethrough and drip or flow through the outlet [02.
  • the filter I04 may be supported in any number of ways, as by a mesh or screen 106 having enlarged pores or passages, for example, of the order of one-sixty-fourths square inch.
  • the condensed anesthetic agent flowing through the outlet 102 may be collected or may be returned to the anesthetic circle in the same manner as described above with regard to the other illustrative embodiments of my invention.
  • the water vapor may be extracted at substantially the same time as the anesthetic agent thereby eliminating the need for preliminary extraction of the water vapor from the exhausted gas.
  • cryogenic techniques are particularly useful for extraction of an anesthetic agent and permitting the extracted agent to be readmitted directly and immediately to the anesthetic circle
  • other techniques may be employed to recover the anesthetic.
  • an absorp tion technique may be employed in which the gas which normally would be exhausted is passed through an absorbent material in which the anesthetic agent is retained. After the absorbent material has become saturated with the anesthetic, it may be processed at a later time to remove the anesthetic agent.
  • activated charcoal displays an extremely high affinity for halothane.
  • a method for administering to a patient, a gaseous mixture which includes a component of inhalation anesthetic, said gaseous mixture being supplied continuously to the patient along a circular path and at a flow rate that is in excess of the patient's rate of uptake and wherein a portion of said gaseous mixture which is not taken up by the patient normally is exhausted from said circular path to the atmosphere, a method of recovering the anesthetic agent from said exhausted gaseous mixture comprising:
  • step olextracting said water vapor from said collected gas comprises:
  • step of cooling said gas to condense said water vapor comprises:
  • step of extracting water vapor from said selected gas comprises:
  • a method as defined in claim 8 wherein said step of readmitting said extracted anesthetic agent into said circular path comprises:
  • An apparatus for delivering an inhalation anesthetic agent comprising.
  • gaseous exchange means interposed along said circular conduction means for enabling gas to be inspired from and expired into said circular conduction means
  • An apparatus as defined in claim 13 further comprising:
  • a device as defined in claim 13 further comprising:
  • An apparatus as defined in claim 19 further comprising:
  • An apparatus as defined in claim 20 wherein said means for extracting said water vapor comprises:
  • An apparatus as defined in claim 14 wherein said means for readmitting said extracted anesthetic agent to said circular conduction means comprises:
  • An apparatus as defined in claim 24 wherein said means for extracting said water vapor and said anesthetic agent at substantially the same time comprises:
  • a filter disposed within and at the bottom of said chamber said filter being adapted to block said ice particles but to enable said anesthetic agent to pass thercthrough;
  • a method as defined in claim 1 further comprising:
  • a method as defined in claim 28 wherein said step of extracting said anesthetic agent and said water vapor from said collected gas at substantially the same time comprises:

Abstract

In a system for administering a volatile inhalation anesthetic agent to a patient at a flow rate that is in excess of the patient''s uptake rate and wherein a portion of the excess anesthetic agent is exhausted from the system, a method and apparatus for recovering the exhausted anesthetic agent. Recovery is effected by collecting the exhausted gas and removing the water vapor either by condensation or with a hygroscopic material. The anesthetic agent is then extracted from the dried gas by a cryogenic process in which the vapors in the anesthetic agent are condensed to a liquid phase or by an absorbent material which is processed later to remove the agent. When employing the condensing process, the anesthetic condensate is collected and may be readmitted directly into the anesthetic system.

Description

United States Patent (72] Inventor Rl hlfi! R- Ju 3,l90,287 6/]965 Miller, Jr 128/1426 8 Trinity Road, Marblehead, Mass. 01945 3,344,852 10/ l 967 Bergson l65/7l :5 12: Primary Examiner-Richard A. Gaudet rimmed ml 45mm": Examiner-J. B. Mitchell y Allomeywolf, Greenfield, Hieken & Sacks I541 J ti flifiill iifififi iitiifi$23315;iiiili'fnlli 29c 7 of the patients uptake rate and wherein a portion of the exl l Cl Ila/188v cess anesthetic agent is exhausted from the system, a method 55/269 and apparatus for recovering the exhausted anesthetic agent. [51] Ill. Cl. ..A6lm 17/00, Recovery is effected by confining the exhausted gas and Bold removing the water vapor either by condensation or with a M /2679; hygroscopic material. The anesthetic agent is then extracted l28/l 88, WI, 186, -1423, I85, I89. I from the dried gas by a cryogenic process in which the vapors I466, 19].! 202, 142, I425, 145.8. I96 in the anesthetic agent are condensed to a liquid phase or by an absorbent material which is processed later to remove the [56] References cued agent. When employing the condensing process, the UNITED STATES PATENTS anesthetic condensate is collected and may be readmitted 3,128,764 4/l964 Koehn l28/l88 directly into the anesthetic system.
PATENTEI] JULI 3 I971 SHEET 1 OF 2 FIG. I
INVENTOR. RICHARD R. JACKSON ATTORNEYS PATENIEU JUU 3 B?! SHEEY 2 BF 2 FIG. 4
FIG. 5
se 62 64 64 U INVENTOR. RICHARD R. JACKSON ATTORNEYS RECOVERY OF ANESTHETIC AGENTS SUMMARY OFTHE INVENTION My invention is directed to a method and apparatus for increasing the efl'tciency of existing systems for administering an inhalation anesthetic agent to a patient. More particularly, it relates to those anesthetic delivery systems in which a portion of the anesthetic agent which is delivered to but not taken up by the patient normally is exhausted to the atmosphere. It is among the primary objects of my invention to provide a method and apparatus for recovering that portion of the anesthetic agent which normally is exhausted from such a system. My invention is particularly useful when the employed anesthetic agent is relatively expensive, such as halothane which is a commonly used name for Lbromo-Z-chloro-l, I, l-trifluoroethane.
A number of systems have been employed in the prior art to deliver a gaseous mixture bearing an inhalation anesthetic to a patient. Among the more common of these systems are the open system" in which that portion of the delivered gaseous mixture which is not taken up by the patient is exhausted completely to the atmosphere and there is no recirculation of any portion of the gaseous mixture to the patient. In an alternative technique, known as the closed system, the anesthetic gases are delivered to the patient and the gases not taken up by the patient then are returned to the circuit so that there is a negligible loss of gas to the atmosphere. In the closed system the rate with which the patients tissues take up the anesthetic agent is dependent on the amount of agent added to the circuit. When administering the anesthesia with a closed circuit system, the amount of agent added to the circuit must be carefully controlled so that as the patients rate of uptake decreases the amount of agent added as the circuit is reduced. Failure to reduce accurately the quantity of agent added to the system, as the depth of anesthesia increases, may tend to cause the patient to become saturated with anesthetic to a degree in excess of that which is necessary for maintenance of anesthesia. If the rate of introduction of anesthetic into the closed circuit is not controlled properly the patient may become saturated dangerously to the degree where cardiac arrest or dangerously low blood pressure may occur.
Another system, preferred in a great number of instances, is the "semiclosed system," in which a portion of the gases flowing through the circuit is exhausted from the circuit. This arrangement permits fresh gases to be introduced into the circuit at a relatively high flow rate. It has been found that when the fresh gas is introduced into the circuit at a flow rate that is considerably greater than the respiratory rate or minute volume of the patient, the tendency for the patient to become saturated excessively with the agent is reduced materially. This eliminates the need to monitor and adjust continually the amount of anesthetic agent introduced into the system as the patients depth of anesthesia increases. One of the disadvantages of employing the semiclosed technique is that a considerable portion of the anesthetic agent, which is not taken up by the patient is exhausted to the atmosphere. When em ploying costly anesthetic agents, such as halothane, this procedure may become quite expensive. It is among the primary objects of my invention to provide an arrangement for recovering that portion of the anesthetic agent that normally is exhausted to the atmosphere. Recovery of the exhausted anesthetic agent enables the semiclosed technique to be employed with an economy approaching that of the closed system.
In accordance with my invention the exhausted gas is collected and then is processed, externally of the anesthesia circle, to remove the particular anesthetic component. The anesthetic then may be readmitted to the circle for immediate reuse or may be stored for use at a later time. A number of methods may be employed for extracting the anesthetic component from the exhausted gas, the illustrative embodiments of my invention employing either a cryogenic or absorption technique.
In the semiclosed system the gases are exhausted from the circle at a location that is downstream from the patient uptake station or inhalation mask so that the exhausted gas may be saturated with water vapor exhaled by the patient. In accordance with the invention, it is desirable to remove as much of this water vapor as possible from the exhausted gas before the anesthetic agent is extracted. This may be effected by passing the gas through a scrubber of hygroscopic material such as silica-gel or, preferably, by cooling the gas to a temperature at which the water vapor will condense to a liquid phase. The remaining gas, which includes the anesthetic agent is then extracted by further cooling to a yet lower temperature at which the anesthetic agent will condense to its liquid phase. The liquid anesthetic agent then may be readmitted directly into the vaporizer of the anesthesia circle and thus be reused immediately.
In addition to the exhaled water vapor, the exhausted gas will contain additional contaminants exhaled by the patient, such as carbon dioxide and, possibly, hydrocarbon gases. In addition, the patient may have been anesthetized earlier with another anesthetic agent and the exhaled gases may include this as well. Another aspect of my invention is directed to a technique and an arrangement for readmitting the anesthetic to a secondary vaporizer, located externally of the anesthesia circle, to isolate the contaminants so that they may be in communication only with the patient from which they originated as well as to preclude contamination of the main source of anesthetic agent.
My technique may be employed to extract the anesthetic agent by a condensation process which enables immediate reuse of the condensate or, alternatively, to the anesthetic agent from the exhausted gas by passing the gas through a material which is capable of absorbing the particular anesthetic agent. For example, when halothane is employed as the anesthetic agent, activated charcoal may be used as the absorbent material. The absorbent material bearing the agent then may be retained for processing at a later time to extract and purify the agent.
Other objects and advantages of my invention will be ap parent from the following detailed description with reference to the accompanying drawings in which like reference characters indicate like elements, and wherein:
FIG. I is an illustration of a conventional semiclosed system for administering an inhalation anesthetic;
FIG. 2 is an illustration of an embodiment of my invention by which the inhalation anesthetic is recovered by a cryogenic process;
FIG. 3 is an illustration of a conventional semiclosed system, modified in accordance with my invention to recover the anesthetic agent which normally would be exhausted to the atmosphere;
FIG. 4 is an illustration of a closed system employing my technique of recovering the anesthetic agent;
FIG. 5 shows an anesthetic delivery system including means for recovering the uninspired anesthetic agent and means for isolating the recovered agent to preclude contamination of the primary source of anesthetic;
FIG. 6 shows an alternative arrangement for extracting cryogenically the anesthetic agent from the uninspired gas; and
FIG. 7 is an illustration of another technique for extracting the anesthetic agent.
As shown in FIG. 1, the conventional semiclosed system for delivering an inhalation anesthetic agent to a patient includes a breathing mask 10 which is positioned over the patients mouth and into which the patient breathes. An inlet hose l2 and an outlet hose 14 are connected to the mask I0 respectively, to deliver a flow of fresh gas to the mask 10 and to conduct the mixed exhaled gas and uninspired gases away from the mask 10. The hoses 12, I4 are provided with one-way valves I6, l8 which insure unidirectional flow through the mask 10. Because the gaseous mixture flowing through the outlet hose 14 includes a component of exhaled gases, such as carbon dioxide, it is common practice to process the gas flow ing through the outlet hose 14 to remove the carbon dioxide before that gas is recircled through the inlet hose [2 to the mask To this end a canister is connected to the downstream end of the outlet hose [4. The canister 20 is filled with a material which absorbs readily carbon dioxide, such as sodalime. The inlet hose [2 is connected to the other end of the canister 20 to receive and conduct the processed gas, which includes a previously uninspired portion of inhalation anesthetic, to the mask 10. A conventional reservoir bag 22 may be connected to the outlet hose l4 downstream of the one-way valve 18. The circuitous path defined by the inlet hose l2, mask [0, outlet house 14 and canister 20 is referred to commonly as the anesthetic circle."
In the semiclosed system shown in FIG. 1, a fresh mixture of gases, including the anesthetic agent, is introduced continually to the anesthetic circle through the hose 24 which leads into the outlet end of the canister 20 so that the gases flowing through the hose 24 may mix with the processed gas that has passed through the soda-lime in the canister 20. This mixturc is then delivered through the oneway valve 16 and inlet hose 1] to the breathing mask It). The fresh, gaseous mixture passing through the hose 24 may include a mixture of oxygen and nitrous oxide which may be supplied in the desired proportions from a source 26. The anesthetic agent is combined with the nitrous oxide-oxygen mixture by means of a vaporizer 28 which is interposed along the hose 24. The vaporizer 28 contains a supply of liquid anesthetic agent, and is effective to vaporize the anesthetic agent so that it will mix, in predetermined and controllable ratios, with the oxygen-nitrous oxide mixture flowing into the vaporizer 28. The flow rates em ployed and the proportions in which the various gases are mixed depends on the type of delivery system employed, the type of anesthetic agent utilized as well as the needs of the par-- ticular patient to be anesthetized. For example, in a semiclosed system in which halothane is employed as the anesthetic agent, the flow rate may be between 2-7 liters per minute of nitrous oxide-oxygen mixture of which approxi mately 0.5-2.5 percent of which is vaporized halothane. A number of such vaporizers are available commercially, and, although they operate under somewhat different principles, they all are effective to produce the same results of vaporizing and mixing the anesthetic agent with the fresh flow of gas introduced to the anesthetic circle.
One of the characteristics inherent in the semiclosed system is that the gaseous mixture flows through the anesthetic circle at a flow rate that is greater than the uptake rate of the patient Furthermore, because fresh gases are being introduced con tinually to the anesthetic circle by the supply hose 24, it is necessary to bleed or otherwise permit some of the gas to be exhausted or otherwise escape from the anesthetic circle, This is accomplished commonly by means of a pressure responsive pop-off valve 30, formed integrally with canister 20 and which is effective to enable the excess gas in the circle to be exhausted to the atmosphere. The pop-off valve 30 is located in the anesthetic circle so that the gas which escapes through the valve 30 comes from the outlet hose 14. Because one of the gaseous components flowing through the outlet hose 14 in-- cludes that portion of the anesthetic agent which was not taken up by the patient at the mask [0, some of this excess anesthetic necessarily will be exhausted to the atmosphere through the pop-off valve 30. This practice can become quite expensive when employing a costly anesthetic agent and it is among the primary objects of my invention to collect the gaseous mixture which normally would be exhausted and then to extract the anesthetic agent therefrom so that it may be reused.
A number of methods may be employed for extracting the anesthetic agent from the exhausted gas, It should be noted that the gas flowing from the mask 10 to the hose 14 will include a number of gaseous constituents generated and exhaled by the patient in addition to the uninspired anesthetic and car bon dioxide. Among the more common of the exhaled constituents which is present in a significant concentration is water vapor, and, in the preferred embodiment of my IIWCH tion, a considerable portion of the water vapor is removed initially from the gas.
As shown in FIG. 2, which illustrates an arrangement for extracting the anesthetic agent, the exhausted gas is collected in a bleed hose 32 which conducts the gas to a first condenser 34. The condenser 34 includes a condenser coil 36 which is in communication with the bleed hose 32, the coil 36 being immersed in a ice-water bath 38. By reducing the temperature of the gas to this level, most of the water vapor present in the gas will condense on the inner walls of the coil 36 The coil 36 terminates in an outlet to 40 which is connected to a water trap 42. The water trap is effective to permit the remaining gases to pass thercthrough into the tube 44, but to preclude the condensed water vapor from passing therethrough. lt should be noted that little, if any, of the anesthetic agent will be condensed when reduced to the temperature (0 C.) of the first condenser 34. This is due to the fact that anesthetic agents, such as halothanc are of markedly greater volatility than water and are charactcrizcd by their considerably greater vapor pressures for a given temperature. After passing through the water trap 32, the remaining gases are passed through a second condenser 46 which includes a condenser coil 48 which is immersed in solid carbon dioxide (dry ice) at a temperature of approximately minus 70 C. Reduction of the temperature to this level is effective to reduce the vapor pres sure of the anesthetic agent to a level wherein it will condense to the liquid phase on the inner surface of the coil 48. For example, when subjecting a halothanc-bearing mixture to the second condenser 46, the partial pressure of the halothane is reduced to less than i millimeter Hg. which is adequate to enable condensation and recovery of practically all of the halothane. A drip tube 52 is connected to the outlet of the coil 48 and directs the condensed agent to a container 54 in which it may be collected. Other arrangements, such as a silica-gel scrubber, may be employed, in place of the condenser arrangement for removing the water vapor from the collected gas before extraction ofthc anesthetic agent.
The foregoing cryogenic arrangement for extracting the anesthetic agent from the gas is shown, in FIG. 3, as employed in a conventional semiclosed anesthetic delivery system. ln this arrangement the bleed hose 32 is connected directly to the pop-off valve 30 to collect and conduct the gases, which normally would be exhausted to the atmosphere, to the condensers 34 and 46. The drip tube 52, leading from the second condenser 46 is connected to a liquid trap 53 which retains the condensed agent that permits the remaining, unwanted gases to be eliminated from the system. The trap is connected to the vaporizer 28 to enable the recovered liquid anesthetic to be readmitted into the delivery system.
The foregoing arrangement may be employed in a semiclosed system in which the vaporizer 28 is located outside the anesthetic circle, as described thus far, or in an arrangement in which the vaporizer is located within the anesthetic circle. Such an arrangement is shown in FIG. 4 and includes a vaporizer 54 which receives the flow from the outlet hose l4 and which is connected to the inlet of the canister 20 by the hose 56 The source 26 of the fresh gases is connected to the vaporizer 54 by the conduit 58. The anesthetic agent which is extracted from the exhausted gas is readmitted to the anesthetic circle by the drip-tube 52 and liquid trap 53 which is connected to the vaporizer 54.
Because the patient may emit a variety of contaminant gaseous constituents from his lungs, such as volatile hydrocarbons or traces of another anesthetic agent that was previously administered to the patient, it may be desirable to isolate the ex hausted gas and the anesthetic agent extracted therefrom from the main source of agent stored in the vaporizer. This is particularly true if it is not possible practicably to eliminate these contaminants from the recovered anesthetic agent. In order to avoid contamination of the main supply of anesthetic agent which is retained in the vaporizer, an arrangement may be employed, in accordance with my invention, to isolate the ex tracted anesthetic agent from that contained in the vaporizer. As shown in FIG. 5, this arrangement includes an anesthetic circle system in which a small, secondary vaporizer 60 is employed to collect the extracted anesthetic agent from the drip tube 52. No portion of the collected anesthetic is redirected to the main vaporizer 28 so that if any contaminants are present in the extracted anesthetic agent, they will not affect the purity of the main supply of anesthetic agent in the main vaporizer 28. The recovered anesthetic is vaporized in the secondary vaporizer 60 and is combined with an oxygen-nitrous oxide mixture which flows from a source 62 through the conduit 64 into the secondary vaporizer 60. A fine flow meter 66 is interposed along the conduit 64 to regulate the flow of fresh gas through the secondary vaporizer 60 so that the relatively low flow of gaseous mixture from the secondary vaporizer 60 back to the anesthetic circle along the conduit 68 will contain a large proportion of agent, for example, of the order of 30 per cent concentration. This mixture, introduced to the anesthetic circle through the conduit 68, is supplemented by and mixed with a flow of fresh gas from the source 26 which is regulated by the coarse flow meter 70. The flow meter 70 is adjusted so that the fresh gases which are mixed with the vaporized anesthetic agent in the main vaporizer 28 will be delivered to the anesthetic circle along the conduit 14 at a flow rate and concentration which will dilute the relatively low flow and high concentration of the gas introduced along the conduit 68 to a concentration which may be safely administered to the patient. It will be appreciated that this arrangement isolates completely the extracted anesthetic agent and any contaminants contained therein from the main supply of anesthetic in the main vaporizer 28.
It should be appreciated that other arrangements may be provided for cooling the exhausted gas to extract the anesthetic agent in its liquid phase. Such an alternative arrangement is shown in FIG. 6 and includes a source 72 of liquid oxygen 74 at a temperature of approximately minus 220 C. As shown in FIG. 6, the source 72 may comprise a Dewar flask. The oxygen is admitted to an insulated condenser 76 by a tube 78, the outlet of which is controlled by a thermostatic valve 80 which is adapted to regulate the flow of oxygen into the condenser 76, thereby to maintain the condenser at a temperature which is sufficient to condense substantially all of the anesthetic agent but which will not render the agent too viscous to handle. For example, when the anesthetic agent is halothane the thermostatic valve 80 should control the admis sion of oxygen so that the temperature within the condenser 76 if of the order of minus 70 C. A condenser coil 82 is con tained within the condenser 76 and receives the predried gas through the inlet 84 and directs the condensed anesthetic agent to the outlet 86 into a trap 88 which retains the recovered fluid anesthetic agent. The trap 88, of course, is provided with a vent 90 through which the unrecov'ered, unwanted gases may escape to the atmosphere. The recovered anesthetic agent may be stored for subsequent use or may be readmitted directly into the anesthetic circle in the manners described above. Additionally, the condenser 76 may be provided with an outlet for the evaporated oxygen which may be redirected to the source of the fresh gas flow.
My invention, as described thus far, relates to an arrange ment in which the water vapor is extracted from the exhausted gaseous mixture before and in separate step from the extrac' tion of the anesthetic agent, In some instances, however, it may be desirable to separate simultaneously the water vapor and anesthetic agent by employing an arrangement as shown in FIG. 7, This arrangement differs from those described previously in that the bleed hose 32 from the pop off valve 30 leads directly into the upper end ofa cryogenic condenser 94. The condenser 94 includes an internal chamber 96 in which is mounted a plurality of condenser plates 98. The chamber 96 is maintained at a temperature that is low enough to condense substantially all of the anesthetic agent introduced into the chamber 96 through the bleed hose 32. Thus, when it is desired to extract halothane, the chamber 96 may be maintained at approximately 70 C by immersing the chamber 96 in a bath of solid carbon dioxide 50' and chamber 96. Other techniques may be employed to maintain the chamber 96 at the desired temperature. When the exhausted gas flows through the bleed hose 32 into the chamber 96 it will be subjected to an immediate and rapid temperature drop which will cause the water vapor in the exhausted gas to condense rapidly into minute ice particles ranging in size from approximately 0.5 to 20 microns in diameter. The temperature of the chamber 96 will cause the anesthetic agent to condense to its liquid phase on and about the condenser plates 98 from which the condensed anesthetic agent may drip downwardly toward an outlet 102 formed in the bottom of the chamber 96. The ice particles will also gravitate and drift downwardly toward the outlet 102 and may form a slurry with the condensed anesthetic agent. The ice particles are separated from the condensed anesthetic agent and other gases passing through the chamber 96 by means ofa suitable filter 104, such as is available commercially from the Millipore Corporation. For example, a Millipore filter effective to block the passage of particles l micron in diameter and smaller would be suitable to separate most of the frozen ice particles, yet would permit the condensed liquid anesthetic agent and other gases to pass therethrough and drip or flow through the outlet [02. The filter I04 may be supported in any number of ways, as by a mesh or screen 106 having enlarged pores or passages, for example, of the order of one-sixty-fourths square inch. The condensed anesthetic agent flowing through the outlet 102 may be collected or may be returned to the anesthetic circle in the same manner as described above with regard to the other illustrative embodiments of my invention. Thus, by subjecting the exhausted gaseous mixture to a rapid, extreme temperature drop, the water vapor may be extracted at substantially the same time as the anesthetic agent thereby eliminating the need for preliminary extraction of the water vapor from the exhausted gas.
Although the foregoing cryogenic techniques are particularly useful for extraction of an anesthetic agent and permitting the extracted agent to be readmitted directly and immediately to the anesthetic circle, other techniques may be employed to recover the anesthetic. For example, an absorp tion technique may be employed in which the gas which normally would be exhausted is passed through an absorbent material in which the anesthetic agent is retained. After the absorbent material has become saturated with the anesthetic, it may be processed at a later time to remove the anesthetic agent. For example, activated charcoal displays an extremely high affinity for halothane. Thus when recovering halothane with activated charcoal, the water vapor in the exhausted gas is removed initially and then the remaining gas is passed through the activated charcoal which will absorb and retain the halothane, gram for gram. The charcoal is subjected subsequently to a reduced pressure distillation process at a later time. This technique is advantageous in that it is extremely simple and provides complete absorption.
it should be appreciated that, although the invention has been described herein primarily as being employed in a serniclosed system, it is equally suitable for recovery of the anesthetic agent exhausted to the atmosphere in an open system or any other system in which all or a portion of the anesthetic agent which is not taken up is exhausted to the atmosphere.
It should be understood that the foregoing description is intended merely to be illustrative of my invention and other modifications and embodiments will be apparent to those skilled in the art without departing from its spirit.
Having thus described my invention, 1 claim:
I. In a method for administering, to a patient, a gaseous mixture which includes a component of inhalation anesthetic, said gaseous mixture being supplied continuously to the patient along a circular path and at a flow rate that is in excess of the patient's rate of uptake and wherein a portion of said gaseous mixture which is not taken up by the patient normally is exhausted from said circular path to the atmosphere, a method of recovering the anesthetic agent from said exhausted gaseous mixture comprising:
collecting said exhausted portion of said gaseous mixture externally of said circular path;
extracting said anesthetic agent from said collected gas ex ternally of said circular path; and,
readmitting said extracted anesthetic agent into said circular path to recombine said anesthetic agent with said gaseous mixture that is being supplied to the patient.
2. A method as defined in claim 1 wherein said step of exlracting said anesthetic agent is preceded by the step of ex tracting water vapor from said collected gas.
3. The method as defined in claim 2 wherein said step olextracting said water vapor from said collected gas comprises:
cooling said collected gas to a temperature wherein the water vapor in said gas condenses to the liquid phase.
4. A method as defined in claim 3 wherein said step of cooling said gas to condense said water vapor comprises:
passing said collected gas through a condenser; and
maintaining said condenser at a temperature that approximates C.
5. The method as defined in claim 2 wherein said step of extracting water vapor from said selected gas comprises:
passing said gas through a scrubber having a relatively high afi'mity for water vapor. 6. The method asdefined in claim 5 wherein said scrubber is formed from silica-gel.
7. In a method for supplying a gaseous mixture to an uptake station, said gaseous mixture including an inhalation anesthetic agent, the improvement comprising, in combina tion:
supplying a carrier gas to a vaporization station; combining the vaporized phase of said anesthetic agent with said carrier gas at said vaporization station thereby to form a mixture of said carrier gas and anesthetic agent;
conducting said gaseous mixture along a first path to said uptake station thereby to enable a patient to inspire a por tion of said gaseous mixture as it flows past said uptake station;
conducting the uninspired portion of said gaseous mixture and the gases expired by the patient away from said up take station along a second path;
extracting said anesthetic agent from said gas conducted along said second path; and
readmitting said extracted anesthetic agent to said vaporization station.
8. In a method of supplying a gaseous mixture including a component anesthetic agent by providing a circular path for conducting substantially unidirectional gaseous flow past an induction station at which gases may be inspired from or expired into said circular path and in which a portion of the gaseous mixture expired into said circular path is exhausted from said circular path, the improvement comprising, in combina tion:
supplying a carrier gas to a vaporization chamber which is in communication with said circular path; vaporizing said anesthetic agent at said vaporization station and combining said vaporized anesthetic with said carrier gas thereby to form an anesthetic bearing carrier gas;
conducting said gaseous mixture from said vaporization sta tion to said circular path to enable said anesthetic agent to flow to said induction station;
collecting that portion of said gaseous mixture which is ex hausted from said circular path;
extracting the anesthetic agent from said collect gaseous mixture; and
readmitting said extracted anesthetic agent into said circu' lar path.
9. A method as defined in claim 8 wherein said extracted agent is readmitted at said vaporization station.
It]. A method as defined in claim 8 wherein the step ofex tracting the anesthetic agent from said collected gaseous mix ture is preceded by the step of extracting water vapor from said collected portion of said gaseous mixture.
ll. A method as defined in claim 8 wherein the gas expired into said circular path at said induction station includes a component of carbon dioxide and wherein said method further comprises:
eliminating said carbon dioxide from said gas flowing through said circular path.
12, A method as defined in claim 8 wherein said step of readmitting said extracted anesthetic agent into said circular path comprises:
conducting said extracted anesthetic agent to a secondary vaporization station,
supplying a carrier gas to said secondary vaporization station; vaporizing said extracted anesthetic agent within said secondary vaporization station thereby to form a secon dary mixture of carrier gas and anesthetic agent; and
conducting said secondary mixture from said secondary vaporization station into said circular path.
13, An apparatus for delivering an inhalation anesthetic agent comprising.
circular gas flow conduction means;
gaseous exchange means interposed along said circular conduction means for enabling gas to be inspired from and expired into said circular conduction means;
means for vaporizing said anesthetic agent and for combin ing said vaporized anesthetic agent with a carrier gas, thereby to form a first gaseous mixture;
means communicating said vaporizing means with said circular conduction means to enable said first gaseous mixture to flow into and through said circular conduction means;
means for effecting substantially unidirectional flow of gas within said circular conduction means in a direction that will cause said first gaseous mixture to flow from said vaporizing means to said gaseous exchange means;
means interposed along said circular conduction means downstream of said gaseous exchange means, for exhausting from said circular conduction means a portion of a second gaseous mixture flowing from said exchange means;
means for collecting said exhausted second gaseous mixture externally of said circular conduction means; and
means for extracting the component of anesthetic agent from said collected, second gaseous mixture while said second gaseous mixture is external of said circular conduction means.
14. An apparatus as defined in claim 13 further comprising:
means for readmitting said extracted anesthetic agent into said circular conduction means.
15. An apparatus as defined in claim 14 wherein said means for readmitting said extracted anesthetic agent into said circular conduction means comprises:
means communicating said anesthetic extracting means with said vaporizing means.
16. A device as defined in claim 13 further comprising:
means for extracting water vapor contained within said second gaseous mixture before said anesthetic agent is ex tracted therefrom.
17. An apparatus as defined in claim [6 wherein said means for extracting said water vapor and said anesthetic agent comprises:
means for cooiing said second gaseous mixture to a temperature wherein substantially all of the water vapor present therein is condensed to the liquid phase; and means for thereafter cooling the remaining components of said second gaseous mixture to a degree wherein said anesthetic agent is condensed into a liquid phase.
18. An apparatus as defined in claim 16 wherein said means for extracting said water vapor from said gaseous mixture comprises a Silica-gel scrubber.
[9. An apparatus as defined in claim 13 wherein said means for extracting said anesthetic agent from said second gaseous mixture comprises:
means for cooling said second gaseous mixture to a teniperature wherein said anesthetic agent is condensed to its liquid phase.
20. An apparatus as defined in claim 19 further comprising:
means for extracting water vapor contained within said second gaseous mixture before said anesthetic agent is extracted therefrom.
2!. An apparatus as defined in claim 20 wherein said means for extracting said water vapor comprises:
means for cooling said second gaseous mixture to a tcmperature wherein substantially all of the water vapor present therein is condensed to the liquid phase.
22. An apparatus as defined in claim 20 wherein said means for extracting said water vapor from said gaseous mixture comprises a hydroscopic material through which said second gaseous mixture is passed.
23. An apparatus as defined in claim 14 wherein said means for readmitting said extracted anesthetic agent to said circular conduction means comprises:
secondary anesthetic vaporizing means;
means for delivery said extracted anesthetic agent to said secondary vaporizing means;
means communicating a secondary carrier gas to said secondary vaporizing means, thereby to form a third gaseous mixture;
means communicating said third gaseous mixture from said secondary vaporizing means to said circular conduction means.
24. An apparatus as defined in claim 13 wherein said means for extracting the component of anesthetic agent from said collected, second gaseous mixture further comprises:
means for extracting water vapor contained within said second gaseous mixture at substantially the same time as said extraction of said anesthetic agent therefrom.
25. An apparatus as defined in claim 24 wherein said means for extracting said water vapor and said anesthetic agent at substantially the same time comprises:
a condensing chamber;
means for communicating said second gaseous mixture to said condensing chamber;
means maintaining said chamber at a reduced temperature level at which the water vapor in said second gaseous mixture will freeze immediately into minute ice particles and wherein the anesthetic agent in said second gaseous mixture will condense to the liquid phase; and
means for separating said ice particles from said condensed anesthetic agent.
26. An apparatus as defined in claim 25 wherein said means for separating said ice particles and said condensed anesthetic agent comprises:
a filter disposed within and at the bottom of said chamber said filter being adapted to block said ice particles but to enable said anesthetic agent to pass thercthrough; and
means enabling said filtered anesthetic agent to be col lected.
27. In apparatus as defined in claim 25 further comprising:
means for readmitting said extracted anesthetic agent to said circular conduction means.
28. A method as defined in claim 1 further comprising:
extracting the water vapor from said collected gas at substantially the same time as said extraction of said anesthetic agent therefrom.
29. A method as defined in claim 28 wherein said step of extracting said anesthetic agent and said water vapor from said collected gas at substantially the same time comprises:
subjecting said collected gas to rapid temperature drop to a degree wherein said water vapor condenses into fine ice particles and wherein said anesthetic agent is condensed to the liquid phase; and
separating said solidified ice particles from said condensed anesthetic agent.

Claims (29)

1. In a method for administering, to a patient, a gaseous mixture which includes a component of inhalation anesthetic, said gaseous mixture being supplied continuously to the patient along a circular path and at a flow rate that is in excess of the patient''s rate of uptake and wherein a portion of said gaseous mixture which is not taken up by the patient normally is exhausted from said circular path to the atmosphere, a method of recovering the anesthetic agent from said exhausted gaseous mixture comprising: collecting said exhausted portion of said gaseous mixture externally of said circular path; extracting said anesthetic agent from said collected gas externally of said circular path; and, readmitting said extracted anesthetic agent into said circular path to recombine said anesthetic agent with said gaseous mixture that is being supplied to the patient.
2. A method as defined in claim 1 wherein said step of extracting said anesthetic agent is preceded by the step of extracting water vapor from said collected gas.
3. The method as defined in claim 2 wherein said step of extracting said water vapor from said collected gas comprises: cooling said collected gas to a temperature wherein the water vapor in said gas condenses to the liquid phase.
4. A method as defined in claim 3 wherein said step of cooling said gas to condense said water vapoR comprises: passing said collected gas through a condenser; and maintaining said condenser at a temperature that approximates 0* C.
5. The method as defined in claim 2 wherein said step of extracting water vapor from said selected gas comprises: passing said gas through a scrubber having a relatively high affinity for water vapor.
6. The method as defined in claim 5 wherein said scrubber is formed from silica-gel.
7. In a method for supplying a gaseous mixture to an uptake station, said gaseous mixture including an inhalation anesthetic agent, the improvement comprising, in combination: supplying a carrier gas to a vaporization station; combining the vaporized phase of said anesthetic agent with said carrier gas at said vaporization station thereby to form a mixture of said carrier gas and anesthetic agent; conducting said gaseous mixture along a first path to said uptake station thereby to enable a patient to inspire a portion of said gaseous mixture as it flows past said uptake station; conducting the uninspired portion of said gaseous mixture and the gases expired by the patient away from said uptake station along a second path; extracting said anesthetic agent from said gas conducted along said second path; and readmitting said extracted anesthetic agent to said vaporization station.
8. In a method of supplying a gaseous mixture including a component anesthetic agent by providing a circular path for conducting substantially unidirectional gaseous flow past an induction station at which gases may be inspired from or expired into said circular path and in which a portion of the gaseous mixture expired into said circular path is exhausted from said circular path, the improvement comprising, in combination: supplying a carrier gas to a vaporization chamber which is in communication with said circular path; vaporizing said anesthetic agent at said vaporization station and combining said vaporized anesthetic with said carrier gas thereby to form an anesthetic bearing carrier gas; conducting said gaseous mixture from said vaporization station to said circular path to enable said anesthetic agent to flow to said induction station; collecting that portion of said gaseous mixture which is exhausted from said circular path; extracting the anesthetic agent from said collect gaseous mixture; and readmitting said extracted anesthetic agent into said circular path.
9. A method as defined in claim 8 wherein said extracted agent is readmitted at said vaporization station.
10. A method as defined in claim 8 wherein the step of extracting the anesthetic agent from said collected gaseous mixture is preceded by the step of extracting water vapor from said collected portion of said gaseous mixture.
11. A method as defined in claim 8 wherein the gas expired into said circular path at said induction station includes a component of carbon dioxide and wherein said method further comprises: eliminating said carbon dioxide from said gas flowing through said circular path.
12. A method as defined in claim 8 wherein said step of readmitting said extracted anesthetic agent into said circular path comprises: conducting said extracted anesthetic agent to a secondary vaporization station; supplying a carrier gas to said secondary vaporization station; vaporizing said extracted anesthetic agent within said secondary vaporization station thereby to form a secondary mixture of carrier gas and anesthetic agent; and conducting said secondary mixture from said secondary vaporization station into said circular path.
13. An apparatus for delivering an inhalation anesthetic agent comprising: circular gas flow conduction means; gaseous exchange means interposed along said circular conduction means for enabling gas to be inspired from and expired into said circular conduction means; means for vaporizing said anesthetic agent and for combining said vaPorized anesthetic agent with a carrier gas, thereby to form a first gaseous mixture; means communicating said vaporizing means with said circular conduction means to enable said first gaseous mixture to flow into and through said circular conduction means; means for effecting substantially unidirectional flow of gas within said circular conduction means in a direction that will cause said first gaseous mixture to flow from said vaporizing means to said gaseous exchange means; means interposed along said circular conduction means downstream of said gaseous exchange means, for exhausting from said circular conduction means a portion of a second gaseous mixture flowing from said exchange means; means for collecting said exhausted second gaseous mixture externally of said circular conduction means; and means for extracting the component of anesthetic agent from said collected, second gaseous mixture while said second gaseous mixture is external of said circular conduction means.
14. An apparatus as defined in claim 13 further comprising: means for readmitting said extracted anesthetic agent into said circular conduction means.
15. An apparatus as defined in claim 14 wherein said means for readmitting said extracted anesthetic agent into said circular conduction means comprises: means communicating said anesthetic extracting means with said vaporizing means.
16. A device as defined in claim 13 further comprising: means for extracting water vapor contained within said second gaseous mixture before said anesthetic agent is extracted therefrom.
17. An apparatus as defined in claim 16 wherein said means for extracting said water vapor and said anesthetic agent comprises: means for cooling said second gaseous mixture to a temperature wherein substantially all of the water vapor present therein is condensed to the liquid phase; and means for thereafter cooling the remaining components of said second gaseous mixture to a degree wherein said anesthetic agent is condensed into a liquid phase.
18. An apparatus as defined in claim 16 wherein said means for extracting said water vapor from said gaseous mixture comprises a silica-gel scrubber.
19. An apparatus as defined in claim 13 wherein said means for extracting said anesthetic agent from said second gaseous mixture comprises: means for cooling said second gaseous mixture to a temperature wherein said anesthetic agent is condensed to its liquid phase.
20. An apparatus as defined in claim 19 further comprising: means for extracting water vapor contained within said second gaseous mixture before said anesthetic agent is extracted therefrom.
21. An apparatus as defined in claim 20 wherein said means for extracting said water vapor comprises: means for cooling said second gaseous mixture to a temperature wherein substantially all of the water vapor present therein is condensed to the liquid phase.
22. An apparatus as defined in claim 20 wherein said means for extracting said water vapor from said gaseous mixture comprises a hydroscopic material through which said second gaseous mixture is passed.
23. An apparatus as defined in claim 14 wherein said means for readmitting said extracted anesthetic agent to said circular conduction means comprises: secondary anesthetic vaporizing means; means for delivery said extracted anesthetic agent to said secondary vaporizing means; means communicating a secondary carrier gas to said secondary vaporizing means, thereby to form a third gaseous mixture; means communicating said third gaseous mixture from said secondary vaporizing means to said circular conduction means.
24. An apparatus as defined in claim 13 wherein said means for extracting the component of anesthetic agent from said collected, second gaseous mixture further comprises: means for extracting water vapor contained within said second gaseous mixture at substantially the same time as said extraction of said anesthetIc agent therefrom.
25. An apparatus as defined in claim 24 wherein said means for extracting said water vapor and said anesthetic agent at substantially the same time comprises: a condensing chamber; means for communicating said second gaseous mixture to said condensing chamber; means maintaining said chamber at a reduced temperature level at which the water vapor in said second gaseous mixture will freeze immediately into minute ice particles and wherein the anesthetic agent in said second gaseous mixture will condense to the liquid phase; and means for separating said ice particles from said condensed anesthetic agent.
26. An apparatus as defined in claim 25 wherein said means for separating said ice particles and said condensed anesthetic agent comprises: a filter disposed within and at the bottom of said chamber said filter being adapted to block said ice particles but to enable said anesthetic agent to pass therethrough; and means enabling said filtered anesthetic agent to be collected.
27. In apparatus as defined in claim 25 further comprising: means for readmitting said extracted anesthetic agent to said circular conduction means.
28. A method as defined in claim 1 further comprising: extracting the water vapor from said collected gas at substantially the same time as said extraction of said anesthetic agent therefrom.
29. A method as defined in claim 28 wherein said step of extracting said anesthetic agent and said water vapor from said collected gas at substantially the same time comprises: subjecting said collected gas to rapid temperature drop to a degree wherein said water vapor condenses into fine ice particles and wherein said anesthetic agent is condensed to the liquid phase; and separating said solidified ice particles from said condensed anesthetic agent.
US791910*A 1969-01-17 1969-01-17 Recovery of anesthetic agents Expired - Lifetime US3592191A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79191069A 1969-01-17 1969-01-17

Publications (1)

Publication Number Publication Date
US3592191A true US3592191A (en) 1971-07-13

Family

ID=25155184

Family Applications (1)

Application Number Title Priority Date Filing Date
US791910*A Expired - Lifetime US3592191A (en) 1969-01-17 1969-01-17 Recovery of anesthetic agents

Country Status (1)

Country Link
US (1) US3592191A (en)

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3785377A (en) * 1970-11-12 1974-01-15 S Jorgensen Plant, preferably for anaesthesia
US4015599A (en) * 1975-07-21 1977-04-05 Rohm And Haas Company Anesthetic delivery system
US4619269A (en) * 1983-06-29 1986-10-28 Utah Medical Products, Inc. Apparatus and method for monitoring respiratory gas
WO1988007876A1 (en) * 1987-04-14 1988-10-20 Zenova Aktiebolag Method and apparatus for reuse of anesthetics
US4905685A (en) * 1987-04-14 1990-03-06 Siemens Aktiengesellschaft Inhalation anaesthesia equipment
WO1991014476A1 (en) * 1990-03-22 1991-10-03 Methodist Hospital Of Indiana, Inc. Exhaled gas cooling device
US5231980A (en) * 1987-03-04 1993-08-03 Praxair Canada, Inc. Process for the recovery of halogenated hydrocarbons in a gas stream
DE4411533C1 (en) * 1994-04-02 1995-04-06 Draegerwerk Ag Anaesthesia apparatus
US5487380A (en) * 1993-10-19 1996-01-30 Abbott Laboratories Exhaled gas filter and cooler
US5492111A (en) * 1993-01-28 1996-02-20 University Of Iowa Research Foundation Method of elimination of volatile degradation products of sevoflurane during anesthesia
EP0806215A2 (en) * 1996-04-17 1997-11-12 The BOC Group plc Apparatus for recovering an anaesthetic agent
EP0808636A1 (en) * 1991-11-14 1997-11-26 Alliance Pharmaceutical Corporation Method for partial liquid ventilation using fluorocarbons
EP0830164A1 (en) * 1995-03-22 1998-03-25 Michael Bono Improved nebulizer and inhalation device containing same
DE19910845C1 (en) * 1999-03-11 2000-07-27 Draeger Medizintech Gmbh Heat exchanger sublimation process to remove carbon dioxide from respiration gases in anaesthetic applications requires less power than prior art
US6152133A (en) * 1998-07-17 2000-11-28 Siemens Elema Ab Anaesthetic delivery system
US6405539B1 (en) 1997-11-04 2002-06-18 Pneumatic Berlin Gmbh Method and device for recovering gases
US6474335B1 (en) * 1997-12-04 2002-11-05 Medisize B.V. Artificial respiration system
US20030029449A1 (en) * 2001-08-06 2003-02-13 Berry James M. System for removal of halocarbon gas from waste anesthetic gases
US20030233086A1 (en) * 2001-10-17 2003-12-18 Burns William H. Drug delivery system for conscious sedation
US20050155380A1 (en) * 2004-01-20 2005-07-21 Michael Rock Anesthetic agent recovery
US20050166917A1 (en) * 2002-04-23 2005-08-04 Christer Ahlmen Anaesthetic delivery system
US20050196331A1 (en) * 2003-06-04 2005-09-08 Jeffrey Dove Hazardous vapor mitigation system
US20060201503A1 (en) * 2002-10-11 2006-09-14 The Regents Of The University Of California Bymixer apparatus and method for fast-response, adjustable measurement of mixed gas fractions in ventilation circuits
US20060254590A1 (en) * 2005-05-13 2006-11-16 Anesthetic Gas Reclamation, Llc Method and apparatus for self-contained anesthetic gas reclamation
US20060254587A1 (en) * 2005-05-13 2006-11-16 Anesthetic Gas Reclamation, Llc Anesthetic gas reclamation system and method
US20090101010A1 (en) * 2006-02-17 2009-04-23 Zeosys Gmbh Filter cartridge for recuperating halogenated hydrocarbons
US7628034B2 (en) 2005-05-13 2009-12-08 Anesthetic Gas Reclamation, Llc Method of low flow anesthetic gas scavenging and dynamic collection apparatus therefor
US20100089237A1 (en) * 2007-03-16 2010-04-15 L'air Liquide Societe Anonyme Pour L'etude Et L'ex Method for Removing N20 from a Gaseous Flow
US20100192947A1 (en) * 2009-02-04 2010-08-05 Jeff Mandel Anesthetic delivery system and methods of use
US20110082380A1 (en) * 2002-10-11 2011-04-07 The Regents Of The University Of California Bymixer Apparatus and Method for Fast-Response, Adjustable Measurement of Mixed Gas Fractions in Ventilation Circuits
EP2335760A1 (en) * 2009-12-18 2011-06-22 General Electric Company Assembly, method and breathing circuit arrangement for removing moisture of breathing gas
WO2011100826A1 (en) * 2010-02-22 2011-08-25 Class 1 Inc. Apparatus, systems and methods for collecting and reclaiming anaesthetic agents and for removing nitrous oxide from exhaust gases
US8267081B2 (en) 2009-02-20 2012-09-18 Baxter International Inc. Inhaled anesthetic agent therapy and delivery system
US10076620B2 (en) 2012-12-22 2018-09-18 Dmf Medical Incorporated Anesthetic circuit having a hollow fiber membrane
GB2553460B (en) * 2012-11-12 2018-11-21 Biosurgical S L Gas-fluid separation device
US10279132B2 (en) 2012-11-12 2019-05-07 Biosurgical S.L. Agitation apparatus
US10413642B2 (en) 2015-04-28 2019-09-17 James Michael Berry System for dynamic control of medical vacuum
US11679215B2 (en) 2019-11-15 2023-06-20 GE Precision Healthcare LLC Methods and systems for waste gas detection in an anesthetic vaporizer

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128764A (en) * 1960-10-06 1964-04-14 Wilbur R Koehn Anesthesizing apparatus
US3190287A (en) * 1960-12-22 1965-06-22 Air Reduction Breathing system
US3344852A (en) * 1964-06-15 1967-10-03 Bergson Gustav Gas drying apparatus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128764A (en) * 1960-10-06 1964-04-14 Wilbur R Koehn Anesthesizing apparatus
US3190287A (en) * 1960-12-22 1965-06-22 Air Reduction Breathing system
US3344852A (en) * 1964-06-15 1967-10-03 Bergson Gustav Gas drying apparatus

Cited By (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3785377A (en) * 1970-11-12 1974-01-15 S Jorgensen Plant, preferably for anaesthesia
US4015599A (en) * 1975-07-21 1977-04-05 Rohm And Haas Company Anesthetic delivery system
US4619269A (en) * 1983-06-29 1986-10-28 Utah Medical Products, Inc. Apparatus and method for monitoring respiratory gas
US5231980A (en) * 1987-03-04 1993-08-03 Praxair Canada, Inc. Process for the recovery of halogenated hydrocarbons in a gas stream
US5515845A (en) * 1987-03-04 1996-05-14 Praxair Canada Inc. Canister for the recovery of halogenated hydrocarbons in a gas stream
WO1988007876A1 (en) * 1987-04-14 1988-10-20 Zenova Aktiebolag Method and apparatus for reuse of anesthetics
EP0287068B1 (en) * 1987-04-14 1991-11-13 Siemens-Elema AB Ventilator for anesthesia
US5044361A (en) * 1987-04-14 1991-09-03 Zenova Aktiebolag Method and apparatus for reuse of anesthetics
US4905685A (en) * 1987-04-14 1990-03-06 Siemens Aktiengesellschaft Inhalation anaesthesia equipment
WO1991014476A1 (en) * 1990-03-22 1991-10-03 Methodist Hospital Of Indiana, Inc. Exhaled gas cooling device
US5722393A (en) * 1990-03-22 1998-03-03 Methodist Hospital Of Indiana, Inc. Exhaled gas cooling device
EP0808636A1 (en) * 1991-11-14 1997-11-26 Alliance Pharmaceutical Corporation Method for partial liquid ventilation using fluorocarbons
US5492111A (en) * 1993-01-28 1996-02-20 University Of Iowa Research Foundation Method of elimination of volatile degradation products of sevoflurane during anesthesia
US5487380A (en) * 1993-10-19 1996-01-30 Abbott Laboratories Exhaled gas filter and cooler
US5520169A (en) * 1994-04-02 1996-05-28 Dragerwerk Aktiengesellschaft Anesthesia arrangement for recovering gaseous anesthetic agents
DE4411533C1 (en) * 1994-04-02 1995-04-06 Draegerwerk Ag Anaesthesia apparatus
FR2718034A1 (en) * 1994-04-02 1995-10-06 Draegerwerk Ag Anesthesia device.
EP0830164A1 (en) * 1995-03-22 1998-03-25 Michael Bono Improved nebulizer and inhalation device containing same
EP0830164A4 (en) * 1995-03-22 1998-11-18 Michael Bono Improved nebulizer and inhalation device containing same
EP0806215A3 (en) * 1996-04-17 1998-07-01 The BOC Group plc Apparatus for recovering an anaesthetic agent
EP0806215A2 (en) * 1996-04-17 1997-11-12 The BOC Group plc Apparatus for recovering an anaesthetic agent
US6405539B1 (en) 1997-11-04 2002-06-18 Pneumatic Berlin Gmbh Method and device for recovering gases
US6474335B1 (en) * 1997-12-04 2002-11-05 Medisize B.V. Artificial respiration system
US6152133A (en) * 1998-07-17 2000-11-28 Siemens Elema Ab Anaesthetic delivery system
DE19910845C1 (en) * 1999-03-11 2000-07-27 Draeger Medizintech Gmbh Heat exchanger sublimation process to remove carbon dioxide from respiration gases in anaesthetic applications requires less power than prior art
US20030029449A1 (en) * 2001-08-06 2003-02-13 Berry James M. System for removal of halocarbon gas from waste anesthetic gases
US6729329B2 (en) * 2001-08-06 2004-05-04 James M. Berry System for removal of halocarbon gas from waste anesthetic gases
DE10234429B4 (en) * 2001-08-06 2005-09-29 Berry, James M. System for removing halocarbon gas from anesthetic waste gases
US20030233086A1 (en) * 2001-10-17 2003-12-18 Burns William H. Drug delivery system for conscious sedation
US8393321B2 (en) 2001-10-17 2013-03-12 Piramal Critical Care, Inc. Drug delivery system for conscious sedation
US20050166917A1 (en) * 2002-04-23 2005-08-04 Christer Ahlmen Anaesthetic delivery system
US7077136B2 (en) * 2002-04-23 2006-07-18 Maquet Critcal Care Ab Anaesthetic delivery system
US8820325B2 (en) 2002-10-11 2014-09-02 The Regents Of The University Of California Bymixer apparatus and method for fast-response, adjustable measurement of mixed gas fractions in ventilation circuits
US20060201503A1 (en) * 2002-10-11 2006-09-14 The Regents Of The University Of California Bymixer apparatus and method for fast-response, adjustable measurement of mixed gas fractions in ventilation circuits
US20110082380A1 (en) * 2002-10-11 2011-04-07 The Regents Of The University Of California Bymixer Apparatus and Method for Fast-Response, Adjustable Measurement of Mixed Gas Fractions in Ventilation Circuits
US7793659B2 (en) * 2002-10-11 2010-09-14 The Regents Of The University Of California Bymixer apparatus and method for fast-response, adjustable measurement of mixed gas fractions in ventilation circuits
US20050196331A1 (en) * 2003-06-04 2005-09-08 Jeffrey Dove Hazardous vapor mitigation system
US20050155380A1 (en) * 2004-01-20 2005-07-21 Michael Rock Anesthetic agent recovery
US7669438B2 (en) 2005-05-13 2010-03-02 Anesthetic Gas Reclamation, Llc Method and apparatus for anesthetic gas reclamation with compression stage
US20060254587A1 (en) * 2005-05-13 2006-11-16 Anesthetic Gas Reclamation, Llc Anesthetic gas reclamation system and method
US7644594B2 (en) 2005-05-13 2010-01-12 Anesthetic Gas Reclamation, L.L.C. Method and apparatus for self-contained anesthetic gas reclamation
US7596965B2 (en) 2005-05-13 2009-10-06 Anesthetic Gas Reclamation, Llc Anesthetic gas reclamation system and method
US20060254590A1 (en) * 2005-05-13 2006-11-16 Anesthetic Gas Reclamation, Llc Method and apparatus for self-contained anesthetic gas reclamation
US7628034B2 (en) 2005-05-13 2009-12-08 Anesthetic Gas Reclamation, Llc Method of low flow anesthetic gas scavenging and dynamic collection apparatus therefor
US20060254589A1 (en) * 2005-05-13 2006-11-16 Anesthetic Gas Reclamation, Llc Method and apparatus for anesthetic gas reclamation with compression stage
US8038772B2 (en) * 2006-02-17 2011-10-18 Zeosys Gmbh Filter cartridge for recuperating halogenated hydrocarbons
US20090101010A1 (en) * 2006-02-17 2009-04-23 Zeosys Gmbh Filter cartridge for recuperating halogenated hydrocarbons
US8246721B2 (en) * 2007-03-16 2012-08-21 L'air Liquide Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Method for removing N2O from a gaseous flow
US20100089237A1 (en) * 2007-03-16 2010-04-15 L'air Liquide Societe Anonyme Pour L'etude Et L'ex Method for Removing N20 from a Gaseous Flow
US20100192947A1 (en) * 2009-02-04 2010-08-05 Jeff Mandel Anesthetic delivery system and methods of use
US8267081B2 (en) 2009-02-20 2012-09-18 Baxter International Inc. Inhaled anesthetic agent therapy and delivery system
EP2335760A1 (en) * 2009-12-18 2011-06-22 General Electric Company Assembly, method and breathing circuit arrangement for removing moisture of breathing gas
WO2011100826A1 (en) * 2010-02-22 2011-08-25 Class 1 Inc. Apparatus, systems and methods for collecting and reclaiming anaesthetic agents and for removing nitrous oxide from exhaust gases
US8430099B2 (en) 2010-02-22 2013-04-30 Class 1 Inc. Apparatus, systems and method for collecting and reclaiming anaesthetic agents and for removing nitrous oxide from exhaust gases
US9242065B2 (en) 2010-02-22 2016-01-26 Class 1 Inc. Apparatus, systems and method for collecting and reclaiming anaesthetic agents and for removing nitrous oxide from exhaust gases
US9492628B2 (en) 2010-02-22 2016-11-15 Class 1 Inc. Apparatus, systems and method for collecting and reclaiming anaesthetic agents and for removing nitrous oxide from exhaust gases
GB2553460B (en) * 2012-11-12 2018-11-21 Biosurgical S L Gas-fluid separation device
US10279132B2 (en) 2012-11-12 2019-05-07 Biosurgical S.L. Agitation apparatus
EP2916895B1 (en) * 2012-11-12 2019-05-22 Biosurgical S.L. Agitation apparatus
US10076620B2 (en) 2012-12-22 2018-09-18 Dmf Medical Incorporated Anesthetic circuit having a hollow fiber membrane
US10960160B2 (en) 2012-12-22 2021-03-30 Dmf Medical Incorporated Anesthetic circuit having a hollow fiber membrane
US10413642B2 (en) 2015-04-28 2019-09-17 James Michael Berry System for dynamic control of medical vacuum
US11679215B2 (en) 2019-11-15 2023-06-20 GE Precision Healthcare LLC Methods and systems for waste gas detection in an anesthetic vaporizer

Similar Documents

Publication Publication Date Title
US3592191A (en) Recovery of anesthetic agents
JP2845914B2 (en) Method and apparatus for reuse of anesthetic
US5520169A (en) Anesthesia arrangement for recovering gaseous anesthetic agents
US4905685A (en) Inhalation anaesthesia equipment
JP2621908B2 (en) Method for recovering halogenated hydrocarbons in a gas stream
CN115845564A (en) Halocarbon recovery process and system
US20090078254A1 (en) Anesthetic Agent Recovery
US6206002B1 (en) Device and method for recovering anaesthetic during the use of inhaled anaesthetics
JP2001504386A (en) Online recovery of xenon from anesthetic gas
US6471747B1 (en) Method and apparatus for delivering and recovering gasses
JP2001521812A (en) Method and apparatus for gas recovery
GB733473A (en) Improvements relating to breathing apparatus
DuBois et al. Respiratory factors determining the tissue concentrations of inhaled toxic substances
US6408849B1 (en) Recovery and purification of gases used in medical processes
Jänchen et al. Adsorption of desflurane from the scavenging system during high-flow and minimal-flow anaesthesia by zeolites
JP4084523B2 (en) Anesthesia equipment using xenon
EP0938448B1 (en) Process and apparatus for purifying and recovering xenon and other noble gases used in anaesthetic systems
Revell A circulator to eliminate mechanical dead space in circle absorption systems
GRODIN et al. Halothane adsorption complicating the use of soda-lime to humidify anaesthetic gases
GB488250A (en) Apparatus for ether anesthesia
DE3000191A1 (en) Recovery of radioactive xenon from exhaled air - after radio-medical diagnostic procedures by adsorption on active charcoal and subsequent desorption
JPS562287A (en) Closed type respiration apparatus
JPS6374903A (en) Oxygen inhalation apparatus
Branch Ether Anesthesia—A True Gas Technique.
JPH02263705A (en) Oxygen enriching device